Cargando…
Autoantibodies Against Carbonic Anhydrase I and II in Patients with Acute Myeloid Leukemia
OBJECTIVE: Cancer, one of the principal causes of death, is a global social health problem. Autoantibodies developed against the organism’s self-antigens are detected in the sera of subjects with cancer. In recent years carbonic anhydrase (CA) I and II autoantibodies have been shown in some autoimmu...
Autores principales: | Menteşe, Ahmet, Erkut, Nergiz, Demir, Selim, Özer Yaman, Serap, Sümer, Ayşegül, Doğramacı, Şeniz, Alver, Ahmet, Sönmez, Mehmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774362/ https://www.ncbi.nlm.nih.gov/pubmed/28270370 http://dx.doi.org/10.4274/tjh.2016.0341 |
Ejemplares similares
-
Serum carbonic anhydrase I and II autoantibodies in patients with chronic lymphocytic leukaemia
por: Mentese, Ahmet, et al.
Publicado: (2018) -
Detection of autoantibodies against carbonic anhydrase I and II in the plasma of patients with gastric cancer
por: Mentese, Ahmet, et al.
Publicado: (2017) -
The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
por: Erkut, Nergiz, et al.
Publicado: (2016) -
Anti-Carbonic Anhydrase II Antibodies in End-Stage Renal Disease Patients
por: Alver, Ahmet, et al.
Publicado: (2014) -
The Relationship between Serum Carbonic Anhydrase I-II Autoantibody Levels and Diabetic Retinopathy in Type 1 Diabetes Patients
por: Türk, Adem, et al.
Publicado: (2017)